Internal Medicine, Hematology & Oncology · Davenport, IA
NPI
1356352116
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1750 E 53rd Street
Davenport, IA, 52807
Phone (563) 345-4325
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
351,904 services
Medicare patients, 2024
466
Average age 74
Drug cost, 2024
$8.2M
2,368 prescriptions
Company payments, 2025
$1,494
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Susannah P Friemel was code J0174 (injection, lecanemab-irmb, 1 mg), 250,036 times for 16 patients. In total Susannah P Friemel billed 351,904 services in 112 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 250,036 | 16 | $1.05 | $262K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 9,760 | 21 | $2.30 | $22K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 4,637 | 12 | $0.23 | $1,054 |
| J0897 Injection, denosumab, 1 mg | Office | 3,060 | 25 | $20.49 | $63K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,000 | 19 | $15.08 | $30K |
| J1750 Injection, iron dextran, 50 mg | Office | 1,420 | 40 | $13.83 | $20K |
| 85025 Blood Count | Office | 1,173 | 334 | $7.59 | $8,908 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,120 | 19 | $0.09 | $97.71 |
| 99214 Office E&M - Established | Office | 688 | 285 | $92.75 | $64K |
| 96365 Intravenous Infusion, Hydration | Office | 472 | 83 | $47.00 | $22K |
| 80053 Clinical Chemistry | Office | 470 | 128 | $10.27 | $4,825 |
| 96367 Intravenous Infusion, Hydration | Office | 453 | 36 | $21.47 | $9,726 |
| 36415 Venipuncture Blood Collection | Office | 280 | 160 | $7.81 | $2,187 |
| 96372 Injection Administration | Office | 243 | 61 | $10.71 | $2,601 |
| 99213 Office E&M - Established | Office | 230 | 196 | $61.48 | $14K |
By year: 2022 $3.2M for 227,379 services; 2023 $2.7M for 278,349 services; 2024 $2.3M for 351,904 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,173 | 334 | $7.59 | $8,908 |
| 80053 Clinical Chemistry | 470 | 128 | $10.27 | $4,825 |
| 36415 Venipuncture Blood Collection | 280 | 160 | $7.81 | $2,187 |
| 84443 Clinical Chemistry | 113 | 42 | $16.46 | $1,860 |
| 81003 Clinical Chemistry | 22 | 14 | $2.20 | $48.4 |
| 82306 Clinical Chemistry | 15 | 14 | $29.01 | $435 |
Medicare prescription drug claims, 2024
In 2024, the drug Susannah P Friemel prescribed most often to Medicare patients was Levothyroxine Sodium, with 104 prescriptions and refills. In total Susannah P Friemel wrote 2,368 Medicare prescriptions that cost $8.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 104 | 284 | 31 | $964 |
| Letrozole Generic | 99 | 282 | 31 | $2,520 |
| Aranesp Darbepoetin Alfa In Polysorbat | 95 | 96 | 20 | $188K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 92 | 93 | 18 | $2,524 |
| Xarelto Rivaroxaban | 62 | 110 | 14 | $61K |
| Alprazolam Generic | 62 | 69 | 18 | $218 |
| Eliquis Apixaban | 59 | 78 | 13 | $45K |
| Somatuline Depot Lanreotide Acetate | 56 | 56 | Under 11 | $486K |
| Gabapentin Generic | 55 | 73 | Under 11 | $803 |
| Morphine Sulfate Er Morphine Sulfate | 50 | 50 | Under 11 | $975 |
| Prednisone Generic | 46 | 60 | 19 | $269 |
| Jakafi Ruxolitinib Phosphate | 46 | 46 | Under 11 | $760K |
| Potassium Chloride Generic | 45 | 81 | 15 | $466 |
| Reblozyl Luspatercept-Aamt | 41 | 41 | Under 11 | $593K |
| Imatinib Mesylate Generic | 39 | 45 | Under 11 | $46K |
Brand drugs: 945 claims; generic drugs: 1,423 claims; opioid claims: 211.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Susannah P Friemel $1,494 ($1,494 in general payments such as food, travel and fees) from 33 companies. The largest payer was Novartis Pharmaceuticals Corporation with $159.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 10 | $159 |
| Abbvie Inc. ABBV | 7 | $144 |
| Pfizer Inc. PFE | 11 | $139 |
| Janssen Biotech, Inc. JNJ | 6 | $103 |
| Daiichi Sankyo Inc. 4568.T | 4 | $80.97 |
| Eisai Inc. 4523.T | 4 | $78.6 |
| GlaxoSmithKline, LLC. GSK | 3 | $73.1 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $64.62 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $56.65 |
| PharmaEssentia USA Corporation 6446.TW | 3 | $55.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.